Portfolio
Translume, Inc.
Advanced glass micromachining providing new ways to advance sensing, microfluidic and optical communication capabilities(2001)
HandyLab, Inc.
Developing novel clinical diagnostic testing products to improve infectious disease testing(2000)
HealthMedia, Inc.
Delivers tailored behavioral support programs to health management organizations and pharmaceutical companies(1998)
IntraLase
Medical device company that developed an automated procedure for laser vision correction, procedure known as "IntraLasik" or "Bladeless Lasik"(1998)
CardioGene Therapeutics
CardioGene is focused on the development of novel gene therapy products for the treatment of cardiovascular disease (Formerly Genocor, Inc.)(1997)
Biotherapies, Inc.
Commercializing Mammastatin Serum Assay technology used to screen breast cancer risk(1996)
IDUN Pharmaceuticals, Inc.
Therapeutic applications focused on inhibiting caspase activity as treatments for liver disease and inflammation(1994)
Targeted Genetics
Molecular medicines for disease detection and prevention (Formerly Genevo)(1994)
Vetgen, Inc.
Research and genetic disease detection services for all purebred animals(1994)
GlycoGen
Developing immunomodulatory & anti-inflammatory therapeutics based on cell adhesion technology(1992)
SoloHill Engineering, Inc.
Microcarriers and protocols for cell culture applications(1992)
MC3
MC3 Cardiopulmonary, located in Dexter, was founded in 1991 by Robert Bartlett, M.D., a pioneering University of Michigan surgeon, and Scott Merz, PhD, to develop Extracorporeal Membrane Oxygenation (ECMO) technology for patients who would otherwise succumb to heart and lung disease.(1991)
BioQuant
Discovering and developing drugs for oncology, inflammation, immunology, & metabolic diseases(1987)